Health News Releases

May 28, 2014 16:40

Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management

Octapharma sponsored the symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management” during the World Federation of Hemophilia (WFH) World Congress in M

May 27, 2014 21:05

Eppendorf Announces New BioBLU® 50c Single-use Vessel Adaptor Kits

Eppendorf is proud to announce the brand new line of BioBLU 50c Single-use Vessel Adaptor Kits. These convenient adaptor kits allow a 40 L single-use vessel to be used on existing bench-scale controll

May 27, 2014 09:40

European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A

Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authoris

May 23, 2014 17:20

Type 2 Diabetes: European Commission approves Jardiance® (empagliflozin)

For Non-U.S. and Non-U.K. Media The European Commission has granted Marketing Authorisation for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor from Boehringer Ingelheim and Eli L

May 23, 2014 13:20

Antidote for rapid reversal of Pradaxa® (dabigatran etexilate) progresses into next stage of clinical investigation with study in patients

For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announces the next step in the clinical development of idarucizumab*, the investigational antidote for rapid reversal

May 23, 2014 10:55

Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology

Covidien’s (www.covidien.com) Stellarex™ drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective for treatment of peripheral arterial disease (PAD), according to ne

May 22, 2014 20:00

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

During the Late Breaking Clinical Trial sessions at EuroPCR yesterday and published simultaneously in the European Heart Journal, Professor Uwe Zeymer of Klinikum Ludwigshafen, Ludwigshafen, Germany a

May 22, 2014 18:08

South-South Cooperation to Improve Diabetes Care

China, Zimbabwe and Ecuador will have an exclusive opportunity to replicate and adapt a successful diabetic foot care project originally developed in Alexandria, Egypt. This pioneering partner approac

May 22, 2014 15:25

COPD: First Phase III data show lung function benefits of tiotropium + olodaterol fixed-dose combination go beyond tiotropium (Spiriva®) alone

For media outside of the US, the UK & Canada only Boehringer Ingelheim today announced the first Phase III data for the once-daily fixed-dose combination of tiotropium and olodaterol. Results from

May 20, 2014 15:35

Pulmonx Announces First Comprehensive Report of Collateral Ventilation Assessed by the Chartis Endobronchial Catheter in Late Stage Emphysema

Pulmonx (www.pulmonx.com/us-or-international), an emerging leader in interventional pulmonology, announced today that multiple clinical abstracts examining the diagnostic and therapeutic utility of it

May 20, 2014 10:55

Quintiles Executive to Present at Jefferies 2014 Global Healthcare Conference

Quintiles CFO Kevin Gordon will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 in New York City at the Grand Hyatt New York. The Quintiles presentation will beg

May 19, 2014 17:50

Ferring launches Guts4life, An Interactive Online Resource for People with Inflammatory Bowel Disease

Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information, support and inspiration for people concerned with C

May 19, 2014 10:35

IPF Phase III results published in NEJM show nintedanib* slows disease progression

For non-US health media only Results from the Phase III INPULSIS™ trials, published online today in the New England Journal of Medicine, show nintedanib* significantly slowed disease progression in

May 15, 2014 20:05

Neos Therapeutics Announces Issuance of New Patent Covering Composition of Matter for Company’s Novel ADHD Products

Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with a portfolio of proprietary technologies and a late-stage pipeline of innovative controlled re

May 15, 2014 16:15

New analysis shows Boehringer Ingelheim’s Giotrif® (afatinib) is the first treatment to demonstrate significant overall survival benefit for patients with a specific type of lung cancer

For Ex-US and Ex-UK Media Only Boehringer Ingelheim today announced new overall survival results from a post-hoc analysis combining the data of two Phase III trials (LUX-Lung 3 and LUX-Lung 6). The

May 15, 2014 13:40

LFB SA Announces That First Patient Has Begun Treatment with New Coagulation Factor VIIa (Recombinant) in Global Phase 3 Clinical Trial in Hemophilia A and B with Inhibitors

LFB SA, through its U.S. subsidiary, announced today that the first patient has begun treatment with LR769 in a Phase 3 clinical trial of this novel recombinant form of human Factor VIIa in patients w

May 14, 2014 22:30

Wolters Kluwer Health, International AIDS Society Partner to Support Critical Clinical Decision Making

Wolters Kluwer Health (http://goo.gl/o2rWK), a leading global provider of information for healthcare professionals and students, announced today that it has partnered with the International AIDS Socie

May 14, 2014 20:05

Crescendo Bioscience's Vectra(R) DA Predicts Radiographic Progression in Patients With Early Rheumatoid Arthritis

Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq:MYGN), today announced the online publication of a new study in the journal Annals of the Rheumatic Diseases for Cresce

May 13, 2014 14:30

Dr. Paul A. Friedman Joins Verastem Board of Directors

Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the appointment of Paul A. Friedman, M.D. to its

May 13, 2014 11:25

Quintiles Announces Agreement to Acquire Encore Health Resources

As part of its continued efforts to strengthen and expand its service capabilities across the healthcare continuum, Quintiles today announced that it has signed an agreement to acquire Encore Health R

May 08, 2014 11:50

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

For media outside of the U.S., the UK & Canada only Details of a new 6,000 patient study of dabigatran etexilate were announced today at the European Stroke Conference, Nice, France. The RE-SPECT E

May 07, 2014 21:45

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announces first worldwide data from the GLORIA™-AF Registry Programme highlighting substantial regional differences in

May 07, 2014 18:05

Otsuka Wins European Marketing Authorization for Deltyba™ (delamanid)

Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the European Commission has granted a marketing authorization for Deltyba™ (delamanid) for use as part of an appropriate combination regim

May 07, 2014 17:20

Quintiles Executive to Present at Bank of America Merrill Lynch 2014 Health Care Conference

Quintiles CFO Kevin Gordon will present at the Bank of America Merrill Lynch 2014 Health Care Conference on Thursday, May 15, 2014 in Las Vegas at the Encore Wynn. The Quintiles presentation will b

May 07, 2014 13:55

AHRQ Publishes Third Edition of Quintiles-Led Registries User’s Guide

Quintiles today announced that the U.S. Agency for Healthcare Research and Quality (AHRQ) has published the third edition of “Registries for Evaluating Patient Outcomes: A User’s Guide.” Quintiles’ Re

News by Region

News by Industry